Newly Discovered Target For Genital Herpes Vaccine
Researchers at the University of Gothenburg have identified glycoprotein G as a key protein that allows the genital herpes virus (HSV-2) to infect the nervous system, a discovery made through experiments on mice. This protein is now considered a promising target for developing a future vaccine against the widespread viral infection.
Why it matters
Genital herpes is a common, lifelong viral infection with no approved vaccine. This discovery offers a significant breakthrough in understanding the virus's mechanism and provides a potential pathway for developing an effective vaccine, which could improve public health globally.
Researchers at the University of Gothenburg have identified a key protein that allows the virus that causes genital herpes to get into the nervous system. The discovery, made in experiments on mice, could pave the way for future vaccines against the disease.
The article presents scientific findings and research without any discernible political or ideological slant.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in